4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rockwell Medical, Inc. (RMTI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wixom, United States with about 157 employees. Its market capitalization is roughly $23 million. In the fiscal year ended 2025-12-31, RMTI reported $69M in revenue and ($5M) in net income.
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
Interactive charts & full statements → Open the RMTI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $69M | $102M | $84M | $73M |
| Gross Profit | $12M | $18M | $9M | $4M |
| Operating Income (EBIT) | ($5M) | $1M | ($7M) | ($17M) |
| Net Income | ($5M) | ($0M) | ($8M) | ($19M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $17M | $18M | $16M | $16M | $19M | — |
| Gross Profit | $3M | $4M | $2M | $2M | $3M | — |
| Operating Income (EBIT) | ($2M) | ($0M) | ($2M) | ($1M) | ($1M) | — |
| Net Income | ($2M) | ($1M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $57M | $59M | $52M | $47M | — |
| Total Liabilities | $20M | $27M | $31M | $32M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RMTI viewer.
About TickerBase · Data methodology & sources